Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16859261 | 0.97 | MAPK1 (0.44) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL4988385 | 0.93 | MAPK1 (0.41) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| Formaldehyde SCHEMBL17495191 | 0.91 | MAPK1 (0.39) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL3264960 | 0.83 | MAPK1 (0.46) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL22032944 | 0.79 | MAPK1 (0.42) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| Bromide SCHEMBL8857061 | 0.79 | MAPK1 (0.42) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL662176 | 0.79 | MAPK1 (0.42) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL9190770 | 0.77 | KCNN4 (0.43) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL842144 | 0.77 | MAPK1 (0.50) | MAPK1ALDH1A1TAAR1ALOX15ESR1 | |
| SCHEMBL3708602 | 0.77 | MAPK1 (0.50) | MAPK1ALDH1A1TAAR1ALOX15ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | SOLUGEN, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4590418-A1 | WATER REMOVAL IN A PROCESS FOR PREPARING METHYLAL FROM CARBON DIOXIDE | BASF SE (DE) | 2025-07-30 | — | — | EP | claimed |
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | claimed |
| US-20240368452-A1 | COMPOSITIONS AND METHODS FOR THE DISSOLUTION OF IRON SULFIDE | SOLUGEN, INC. (US) | 2024-11-07 | — | — | US | claimed |
| WO-2024062017-A1 | WATER REMOVAL IN A PROCESS FOR PREPARING METHYLAL FROM CARBON DIOXIDE | BASF SE (DE) | 2024-03-28 | — | — | WO | claimed |
| WO-2024062015-A1 | PROCESS FOR REMOVING WATER FROM A MIXTURE CONTAINING METHANOL, WATER AND A CATALYST SYSTEM | BASF SE (DE) | 2024-03-28 | — | — | WO | claimed |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-02-27 | — | — | US | claimed |
| WO-2023156764-A1 | PROCESS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2023-08-24 | — | — | WO | claimed |
| EP-3962891-B1 | METHOD FOR CATALYTICALLY PRODUCING UREA | THYSSENKRUPP IND SOLUTIONS AG (DE) | 2023-03-29 | — | — | EP | claimed |
| EP-3596038-B1 | METAL-CATALYZED ALKOXYCARBONYLATION OF A LACTONE | QATAR FOUND EDUCATION SCIENCE & COMMUNITY DEV (US) | 2022-12-28 | — | — | EP | claimed |
| US-7615671-B2 | Contacting a 1,2-dioxygenated organic compound under hydrogenation conditions in presence of catalyst composition comprising a ruthenium compound, trivalent phosphorus compound selected from 1,1,1-tris(diarylphosphinomethyl)alkyl or substituted alkyl, promoter selected from Lewis acids, protic acids | EASTMAN CHEMICAL COMPANY (US) | 2009-11-10 | — | — | US | claimed |
| US-20090143612-A1 | HYDROGENATION PROCESS FOR THE PREPARATION OF 1,2-DIOLS | EASTMAN CHEMICAL COMPANY (US) | 2009-06-04 | — | — | US | claimed |
| US-20090043102-A1 | METHOD FOR PRODUCING HETEROAROMATIC ALCOHOLS | BASF SE (DE) | 2009-02-12 | — | — | US | claimed |
| US-20090043046-A1 | Process for producing functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2009-02-12 | — | — | US | claimed |
| EP-2022803-A2 | Process for producing functionalized polymers | Bridgestone Corporation (JP) | 2009-02-11 | — | — | EP | claimed |
| EP-0788405-A1 | CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS | THE DOW CHEMICAL COMPANY (US) | 1997-08-13 | — | — | EP | claimed |
| US-5530162-A | Process for the hydrogenation of aryl phosphines and products obtained therefrom | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-06-25 | — | — | US | claimed |
| WO-1996001690-A1 | CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS | THE DOW CHEMICAL COMPANY (US) | 1996-01-25 | — | — | WO | claimed |
| WO-1993021192-A1 | PROCESS FOR THE HYDROGENATION OF ARYL PHOSPHINES AND PRODUCTS OBTTAINED THEREFROM | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-28 | — | — | WO | claimed |
| US-4451680-A | RUTHENIUM COMPOUND, BIDENTATE OR MULTIDENTATE PHOSPHINE, PHOSPHONIUM COMPOUND | TEXACO INC. (US) | 1984-05-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | PFAS, EPM2A, CYP2F1 | MAPK1 2709/4885ALDH1A1 112/4885TAAR1 3490/4885 |
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | MGAT2, SLC7A11, CA1 | MAPK1 2141/4885ALDH1A1 990/4885TAAR1 1082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.